What is Pulse Biosciences, Inc.'s accounts payable?

Pulse Biosciences, Inc. (PLSE) reported accounts payable of -$148K in Q1 2026.

How has Pulse Biosciences, Inc.'s accounts payable changed year-over-year?

Pulse Biosciences, Inc.'s accounts payable decreased by 120.8% year-over-year, from $712K to -$148K.

Pulse Biosciences, Inc. PLSE Accounts Payable

Accounts Payable at other companies

AtriCureATRC

——

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.77B+38.4%

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s accounts payable?: Pulse Biosciences, Inc. (PLSE) reported accounts payable of -$148K in Q1 2026.
How has Pulse Biosciences, Inc.'s accounts payable changed year-over-year?: Pulse Biosciences, Inc.'s accounts payable decreased by 120.8% year-over-year, from $712K to -$148K.